Why the study?
Are circulating cardiac-specific autoantibodies more frequent in patients with clinical myocarditis compared to ischaemic or normal controls?
Are circulating cardiac-specific autoantibodies more frequent in patients with clinical myocarditis compared to ischaemic or normal controls?
Cardiac-specific autoantibodies are significantly more prevalent in patients with clinical myocarditis compared to controls, supporting an autoimmune component in a subset of patients regardless of biopsy findings.
Answers are grounded in this paper and cite their sources.
Supports autoimmune involvement in myocarditis; leaves open whether antibody testing should inform diagnosis or trials.
AIM: Myocarditis and dilated cardiomyopathy may be phases of an organ-specific autoimmune disease of the myocardium. To provide evidence for autoimmune involvement in myocarditis, cardiac autoantibodies were detected in patient sera from the Myocarditis Treatment Trial. METHODS AND RESULTS: Cardiac antibody status was assessed by indirect immunofluorescence and by anti-alpha-myosin enzyme-linked immunosorbent assay in 53 patients from the Myocarditis Treatment Trial (35 males, aged 42 +/- 15 years); all had clinical myocarditis, but only 24 were classified as having histological myocarditis (Dallas criteria). By immunofluorescence, cardiac antibodies were more common in myocarditis (13/53) than in ischaemic (11/186, P = 0.0001) or in normal controls (24/270, P = 0.001). Abnormally raised anti-alpha-myosin antibodies were also more frequent in myocarditis (9/53) than in ischaemic (4/92, P = 0.01) or normal controls (4/203, P = 0.001); 34% of myocarditis patients were positive with one or both tests. Similar proportions of patients with and without histological myocarditis had antibodies by immunofluorescence (8/24 vs 5/29, P = ns) and by enzyme-linked immunosorbent assay (4/24 vs 5/29, P = ns). CONCLUSION: The detection of disease-specific cardiac autoantibodies supports autoimmune involvement in a subset of patients with clinical myocarditis. The lack of correlation of antibody with biopsy features suggests that diagnosis of myocarditis should not be made on histology alone. Autoimmune markers may provide adjunct diagnostic tools and identify patients in whom immunosuppression is of potential benefit.
No takes yet. Share an insight, caveat, or question.
Caforio et al. (1997) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: